0001880438-26-000001.txt : 20260325 0001880438-26-000001.hdr.sgml : 20260325 20260325164223 ACCESSION NUMBER: 0001880438-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260325 DATE AS OF CHANGE: 20260325 EFFECTIVENESS DATE: 20260325 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AN2 Therapeutics, Inc. CENTRAL INDEX KEY: 0001880438 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 820606654 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-577698 FILM NUMBER: 26793048 BUSINESS ADDRESS: STREET 1: 1300 EL CAMINO REAL, SUITE 100 CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: (650) 331-9090 MAIL ADDRESS: STREET 1: 1300 EL CAMINO REAL, SUITE 100 CITY: MENLO PARK STATE: CA ZIP: 94025 D 1 primary_doc.xml X0708 D LIVE 0001880438 AN2 Therapeutics, Inc. 1300 EL CAMINO REAL, SUITE 100 MENLO PARK CA CALIFORNIA 94025 (650) 331-9090 DELAWARE None None Corporation true Eric Easom c/o AN2 Therapeutics, Inc. 1300 EL CAMINO REAL, SUITE 100 MENLO PARK CA CALIFORNIA 94025 Executive Officer Director Joshua Eizen c/o AN2 Therapeutics, Inc. 1300 EL CAMINO REAL, SUITE 100 MENLO PARK CA CALIFORNIA 94025 Executive Officer Lucy Day c/o AN2 Therapeutics, Inc. 1300 EL CAMINO REAL, SUITE 100 MENLO PARK CA CALIFORNIA 94025 Executive Officer Sanjay Chanda c/o AN2 Therapeutics, Inc. 1300 EL CAMINO REAL, SUITE 100 MENLO PARK CA CALIFORNIA 94025 Executive Officer Joseph S. Zakrzewski c/o AN2 Therapeutics, Inc. 1300 EL CAMINO REAL, SUITE 100 MENLO PARK CA CALIFORNIA 94025 Director Kabeer Aziz c/o AN2 Therapeutics, Inc. 1300 EL CAMINO REAL, SUITE 100 MENLO PARK CA CALIFORNIA 94025 Director Rob Readnour c/o AN2 Therapeutics, Inc. 1300 EL CAMINO REAL, SUITE 100 MENLO PARK CA CALIFORNIA 94025 Director Gilbert Lynn Marks c/o AN2 Therapeutics, Inc. 1300 EL CAMINO REAL, SUITE 100 MENLO PARK CA CALIFORNIA 94025 Director Stephanie Wong c/o AN2 Therapeutics, Inc. 1300 EL CAMINO REAL, SUITE 100 MENLO PARK CA CALIFORNIA 94025 Director Patricia Martin c/o AN2 Therapeutics, Inc. 1300 EL CAMINO REAL, SUITE 100 MENLO PARK CA CALIFORNIA 94025 Director Melvin Spigelman c/o AN2 Therapeutics, Inc. 1300 EL CAMINO REAL, SUITE 100 MENLO PARK CA CALIFORNIA 94025 Director Margaret FitzPatrick c/o AN2 Therapeutics, Inc. 1300 EL CAMINO REAL, SUITE 100 MENLO PARK CA CALIFORNIA 94025 Director Pharmaceuticals Decline to Disclose 06b false 2026-03-10 false true true true false 0 Leerink Partners LLC 39011 None None 53 STATE STREET 40TH FLOOR BOSTON MA MASSACHUSETTS 02109 AL ALABAMA AK ALASKA AZ ARIZONA AR ARKANSAS CA CALIFORNIA CO COLORADO CT CONNECTICUT DE DELAWARE DC DISTRICT OF COLUMBIA FL FLORIDA GA GEORGIA HI HAWAII ID IDAHO IL ILLINOIS IN INDIANA IA IOWA KS KANSAS KY KENTUCKY LA LOUISIANA ME MAINE MD MARYLAND MA MASSACHUSETTS MI MICHIGAN MN MINNESOTA MS MISSISSIPPI MO MISSOURI MT MONTANA NE NEBRASKA NV NEVADA NH NEW HAMPSHIRE NJ NEW JERSEY NM NEW MEXICO NY NEW YORK NC NORTH CAROLINA ND NORTH DAKOTA OH OHIO OK OKLAHOMA OR OREGON PA PENNSYLVANIA RI RHODE ISLAND SC SOUTH CAROLINA SD SOUTH DAKOTA TN TENNESSEE TX TEXAS UT UTAH VT VERMONT VA VIRGINIA WA WASHINGTON WV WEST VIRGINIA WI WISCONSIN WY WYOMING false 39999989 39999989 0 false 16 2400003 0 0 false AN2 Therapeutics, Inc. /s/ Eric Easom Eric Easom Chief Executive Officer 2026-03-24